Medivation, Inc. is a biopharmaceutical company focused on the rapid development of novel small molecule drugs to treat critically ill patients with serious diseases for which there are limited treatment options. Medivation aims to transform the treatment of these diseases and offer hope to critically ill patients and their caregivers.

Print   Email Upcoming Events Details on upcoming events are not yet available. Please click here to be notified of all upcoming events. Archived Events May 10, 2010 4:30 PM ET Medivation First Quarter 2010 Financial Results Conference Call Listen to webcast Mar 3, 2010 8:30 AM ET Medivation Phase 3 Dimebon Results Conference Call Listen to webcast = add file to Briefcase